ES2155793A1 - Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes. - Google Patents

Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes.

Info

Publication number
ES2155793A1
ES2155793A1 ES009901547A ES9901547A ES2155793A1 ES 2155793 A1 ES2155793 A1 ES 2155793A1 ES 009901547 A ES009901547 A ES 009901547A ES 9901547 A ES9901547 A ES 9901547A ES 2155793 A1 ES2155793 A1 ES 2155793A1
Authority
ES
Spain
Prior art keywords
particles
monosaccharides
oligosaccharides
cosmetic
crosslinked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009901547A
Other languages
English (en)
Other versions
ES2155793B1 (es
Inventor
Marie-Christine Levy
Nadine Pariot
Florence Edward
Marie-Christine Andry
Eric Perrier
Sylvie Rey-Goutenoire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coletica SA filed Critical Coletica SA
Publication of ES2155793A1 publication Critical patent/ES2155793A1/es
Application granted granted Critical
Publication of ES2155793B1 publication Critical patent/ES2155793B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/795—Composed of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a partículas. Estas partículas contienen, al menos en la superficie, una pared formada por uno o más monosacáridos u oligosacáridos entrecruzados por medio de entrecruzamiento interfacial en emulsión, preferiblemente a temperatura ambiente, entre el (los) monosacárido(s) u oligosacárido(s), que contiene(n) al menos un grupo alcohol primario y un agente de entrecruzamiento acilante polifuncional, preferiblemente un haluro de diácido y particularmente un cloruro de diácido, para producir enlaces éster entre el (los) grupo(s) hidroxilo susceptible(s) de ser acilado(s) del (los) alcohol(es) primario(s) del monosacárido u oligosacárido y los grupos acilo del agente acilante polifuncional. Estas partículas pueden ser utilizadas para la fabricación de composiciones cosméticas, farmacéuticas o alimentarias.
ES009901547A 1998-07-09 1999-07-09 Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes. Expired - Lifetime ES2155793B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808809A FR2780901B1 (fr) 1998-07-09 1998-07-09 Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant

Publications (2)

Publication Number Publication Date
ES2155793A1 true ES2155793A1 (es) 2001-05-16
ES2155793B1 ES2155793B1 (es) 2001-12-01

Family

ID=9528466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009901547A Expired - Lifetime ES2155793B1 (es) 1998-07-09 1999-07-09 Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes.

Country Status (8)

Country Link
US (1) US6197757B1 (es)
JP (1) JP3437797B2 (es)
KR (1) KR100799407B1 (es)
DE (1) DE19932216B4 (es)
ES (1) ES2155793B1 (es)
FR (1) FR2780901B1 (es)
IT (1) IT1311514B1 (es)
NL (1) NL1012517C2 (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2228250A1 (es) * 2002-12-24 2005-04-01 Coletica Particulas que comprenden un biopolimero que es biodegradable bajo el efecto de una onda electromagnetica como la emitida por una radiacion solar.
ES2293816A1 (es) * 2005-02-18 2008-03-16 Engelhard Lyon Polimero reticulado de carbohidrato, particularmente a base de polisacaridos, y/o de oligosacaridos y/o de polioles.
US9133279B2 (en) 2005-02-18 2015-09-15 Basf Beauty Care Solutions France S.A.S. Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010926C2 (nl) * 1998-12-30 2000-07-03 Inst Voor Agrotech Onderzoek Werkwijze voor de bereiding van zetmeeldeeltjes.
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030096013A1 (en) * 2000-12-22 2003-05-22 Jane Werling Preparation of submicron sized particles with polymorph control
US7037528B2 (en) * 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
FR2824756B1 (fr) * 2001-05-16 2005-07-08 Mainelab Microcapsules a base de proteines vegetales
FR2825293B1 (fr) * 2001-06-05 2004-05-07 Coletica Particules solides insolubles dans l'eau traitees, preparation et utilisation
KR100483193B1 (ko) * 2001-06-05 2005-04-14 꼴레띠까 처리된 비수용성 고체 미립자, 그 미립자의 제조 및 사용법
CN1558755A (zh) * 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US6878693B2 (en) 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
US20050227911A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
US20050233003A1 (en) * 2001-09-28 2005-10-20 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US20030084914A1 (en) * 2001-11-08 2003-05-08 L'oreal Cosmetic articles having encapsulated liquid and method of making same
US7700851B2 (en) * 2001-11-13 2010-04-20 U.S. Smokeless Tobacco Company Tobacco nicotine demethylase genomic clone and uses thereof
FR2832632B1 (fr) 2001-11-26 2004-04-23 Mane Fils V Capsule a solubilisation et liberation du contenu rapides
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
FR2847163B1 (fr) * 2002-11-19 2006-07-28 Jean Claude Epiphani Procede d'hydrosolubilisation d'un parfum et solution obtenue par le procede
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
DE10315538A1 (de) * 2003-04-04 2004-10-21 Siemens Ag Teilchen mit einer Membran
AU2004258971A1 (en) * 2003-07-22 2005-02-03 Baxter Healthcare S.A. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
EP1504664A1 (en) * 2003-07-29 2005-02-09 Novartis AG Organic compounds
WO2005009604A1 (en) 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
US20050171194A1 (en) * 2003-12-08 2005-08-04 Yu Ruey J. Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
WO2005060610A2 (en) * 2003-12-11 2005-07-07 The Trustees Of Columbia University In The City Ofnew York Nano-sized particles, processes of making, compositions and uses thereof
CA2564588A1 (en) * 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharide coatings for medical articles
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
TWI342880B (en) * 2005-07-19 2011-06-01 Otsuka Chemical Co Ltd Method for producing sugar chain derivatives, and sugar chain derivatives
CN101277757B (zh) 2005-08-02 2011-11-30 索尔-格尔科技有限公司 非水溶性成分的金属氧化物涂布
RU2313538C2 (ru) * 2005-08-04 2007-12-27 Борис Олегович Майер Хитозановый продукт, способ его получения (варианты)
GB0516761D0 (en) * 2005-08-16 2005-09-21 Eastman Kodak Co Particulate polymeric material
US20070065484A1 (en) * 2005-09-21 2007-03-22 Chudzik Stephen J In situ occlusion using natural biodegradable polysaccharides
US8241656B2 (en) * 2005-09-21 2012-08-14 Surmodics, Inc Articles including natural biodegradable polysaccharides and uses thereof
EP1954245A2 (en) * 2005-11-15 2008-08-13 Baxter International Inc. Compositions of lipoxygenase inhibitors
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
JP5694664B2 (ja) * 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
US20090297626A1 (en) * 2006-11-03 2009-12-03 The Trustees Of Columbia University In The City Of New York Methods for preparing metal oxides
WO2008073295A2 (en) * 2006-12-07 2008-06-19 Surmodics, Inc. Latent stabilization of bioactive agents releasable from implantable medical articles
WO2008080047A2 (en) * 2006-12-23 2008-07-03 Baxter International Inc. Magnetic separation of fine particles from compositions
KR20090125243A (ko) 2007-02-01 2009-12-04 솔-겔 테크놀로지스 리미티드 퍼옥사이드 및 레티노이드를 함유하는 국소 도포용 조성물
BRPI0808160A2 (pt) * 2007-02-01 2014-09-23 Sol Gel Technologies Ltd Processo para revestir um material particulado sólido, insolúvel em água, com um óxido de metal, material particulado revestido, partículas, métodos para tratar uma condição de superfície em um indivíduo, e para prevenir, reduzir, ou eliminar pragas em um local, e, uso de material particulado revestido
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
WO2009137689A2 (en) * 2008-05-07 2009-11-12 Surmodics, Inc. Delivery of nucleic acid complexes from particles
US10099194B2 (en) 2011-03-18 2018-10-16 International Flavors & Fragrances Inc. Microcapsules produced from blended sol-gel precursors and method for producing the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
ITTO20110372A1 (it) * 2011-04-28 2012-10-29 Univ Degli Studi Torino Metodo per la preparazione di nanospugne di destrine
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9056208B2 (en) * 2013-02-07 2015-06-16 Conopco Inc. Personal care compositions that include enrobed sugar
KR102292422B1 (ko) 2013-09-06 2021-08-20 롬 앤드 하아스 컴패니 균일한 다층 폴리머 코팅물을 갖는 산화금속 입자
AU2016311704B2 (en) * 2015-08-24 2018-11-29 Shanxi Yabao Investment Group Co., Ltd Use of dihydroxyacetone in preparation of anti-cancer medicaments
KR101762011B1 (ko) 2015-09-02 2017-07-26 최화숙 3중매트릭스캡슐화가 가능한 화장료 조성물 및 이의 제조방법
CN106349396A (zh) * 2016-08-26 2017-01-25 湖南尔康制药股份有限公司 一种具有超声敏感性的交联淀粉
EA202090965A1 (ru) * 2017-10-16 2020-07-22 Фаэс Фарма, С.А. Водные композиции биластина
WO2021243188A1 (en) * 2020-05-29 2021-12-02 Hemp Synergistics Powderized cannabis oil
KR20240015891A (ko) 2022-07-28 2024-02-06 주식회사 수안향장 이중 매트릭스 캡슐의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017784A1 (fr) * 1992-03-11 1993-09-16 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant
WO1995007689A1 (en) * 1993-09-15 1995-03-23 Ferrosan A/S Compositions containing swelling pharmaceuticals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472835A (en) * 1964-02-12 1969-10-14 American Mach & Foundry Schardinger dextrins
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
US4902788A (en) * 1988-09-29 1990-02-20 Uop Crosslinked cyclodextrins supported on porous refractory inorganic oxides
US4958015A (en) * 1988-09-30 1990-09-18 Uop Preparation of crosslinked cyclodextrin resins with enhanced porosity
US5395620A (en) * 1989-01-31 1995-03-07 Coletica Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
CA2042529C (en) * 1990-08-10 2002-07-30 Chokyun Rha Polysaccharide article and uses therefor
ATE151992T1 (de) * 1991-06-03 1997-05-15 Nycomed Imaging As Verbesserungen im bezug auf kontrastmittel
JPH0778126B2 (ja) * 1992-02-10 1995-08-23 日清紡績株式会社 多糖類真球状粒子及び製造方法
US5321064A (en) * 1992-05-12 1994-06-14 Regents Of The University Of Minnesota Compositions of biodegradable natural and synthetic polymers
SE470353B (sv) * 1992-06-22 1994-01-31 Volvo Penta Ab Båtpropellerdrev med automatiskt trimorgan

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017784A1 (fr) * 1992-03-11 1993-09-16 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant
WO1995007689A1 (en) * 1993-09-15 1995-03-23 Ferrosan A/S Compositions containing swelling pharmaceuticals

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2228250A1 (es) * 2002-12-24 2005-04-01 Coletica Particulas que comprenden un biopolimero que es biodegradable bajo el efecto de una onda electromagnetica como la emitida por una radiacion solar.
US8957001B2 (en) 2002-12-24 2015-02-17 Basf Beauty Care Solutions France Sas Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation
ES2293816A1 (es) * 2005-02-18 2008-03-16 Engelhard Lyon Polimero reticulado de carbohidrato, particularmente a base de polisacaridos, y/o de oligosacaridos y/o de polioles.
US9133279B2 (en) 2005-02-18 2015-09-15 Basf Beauty Care Solutions France S.A.S. Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols

Also Published As

Publication number Publication date
JP3437797B2 (ja) 2003-08-18
IT1311514B1 (it) 2002-03-13
ITTO990599A1 (it) 2001-01-09
KR20000011579A (ko) 2000-02-25
NL1012517C2 (nl) 2000-01-11
FR2780901B1 (fr) 2000-09-29
FR2780901A1 (fr) 2000-01-14
JP2000038402A (ja) 2000-02-08
ES2155793B1 (es) 2001-12-01
US6197757B1 (en) 2001-03-06
KR100799407B1 (ko) 2008-01-30
DE19932216A1 (de) 2000-01-27
DE19932216B4 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
ES2155793A1 (es) Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes.
Gomez d’Ayala et al. Marine derived polysaccharides for biomedical applications: chemical modification approaches
TR199501231A2 (tr) Enterik film kaplama bilesimleri, bunlarla kaplama yöntemi ve kaplanan sekiller.
TR200103241T2 (tr) Yüksek katı içerikli gıda bileşimi
WO2007113222A3 (en) Immunogenic composition
EP2085780A3 (en) Methods and products related to low molecular weight heparin
IL86881A (en) Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
NZ334021A (en) Dietary supplement containing at least two saccharides being the building blocks of glycoproteins
CA2177384A1 (en) Particulate flavour compositions and process to prepare same
BRPI9902623B8 (pt) composições em pó e em emulsão com vitaminas, comprimido efervescente, bebida e método de produção da composição em pó.
DE69839121D1 (de) Wässrige, viskose, klare oder nicht klare zusammensetzungen zur herstellung von weichkapseln und hartkapseln, und herstellungsverfahren von filmen für diese kapseln
CA2250078A1 (en) Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
BRPI0311516A8 (pt) Composição de xampu de condicionamento e seu método de preparo
CA2229271A1 (en) Compositions containing hydroxy acids or retinoids
BR9908578A (pt) Composição cosmética
CA2393072A1 (en) Mono- and disaccharide derivatives
DE59909854D1 (de) Partikulärer wirkstoffträger für die pulmonale applikation
FI925926A (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
HK1047584A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process.
CN106726646A (zh) 一种控油爽肤水及其制备方法
HUP0100622A2 (hu) Nagy molekulatömegű észterolajokat tartalmazó hajkondicionáló készítmény
WO2000015179A3 (en) Cosmetic composition
DK0790780T3 (da) Fedtagtig bestanddel
EP1424081A4 (en) COMPOSITIONS CONTAINING POLYSACCHARIDE AND USE THEREOF

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516